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The respective effects of cholera and Bordetella pertussis toxins were studied in time and concentration de- 
pendent experiments. following glycerol and fatty acid release. GTP and CAMP levels. Cholera toxin, after 
a lag time of 30 min. stimulated linearly GTP and CAMP accumulation and lipolysis (maximal effect: 2-fold 
increase at 5 pg/ml). Pertussis toxin presented a biphasic effect both in time and concentration dependent 
studies. Up to a maximum reached after 2 h with 1.4 units LPF/ml the stimulation affected GTP (3 fold) 
and CAMP (7 fold) levels, glycerol and fatty acid release (15 fold). Beyond this. an inhibition occurred, yleld- 
ing a decrease towards basal values of GTP and CAMP content whereas the glycerol and fatty acid release 
was stopped. These results, which are the first reporting the fluctuation of the GTP content of intact cells 
challenged with bacterial toxins, show a close relationship between GTP and cyclic AMP levels and lipolytic 
activity. 
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1. INTRODUCTION 
In fat cells, lipolytic activity depends on cyclic- 
AMP levels [ 11. Adenylate cyclase stimulation and 
inhibition by hormones is mediated by two 
separate guanine nucleotide-binding regulatory 
components, N, [2-41 and Ni [5-71, respectively. 
N, is activated by cholera toxin which ADP 
ribosylates its cy subunit and promotes the dissocia- 
tion of the heterodimer W-P [4,8,9]. Ni is 
dissociated by another toxin from Bordetella per- 
tussis (IAP) which ADP ribosylates and activates 
its cy subunit [lo]. 
While ADP-ribosylation and N, inhibits the N,- 
associated GTPase activity [ 11,121, ADP- 
ribosylation of Ni decreases the rate of formation 
of GTP bound Ni and prevents its hydrolysis into 
GTP-bound Ni by the associated GTPase [ 13- 151. 
Most work has been done in acellular systems 
with the concentration of the various components, 
in particular that of GTP or its stable analogue, 
fixed by the experimenter [16]. Its seemed of great 
interest o follow the consequences of toxins treat- 
ment of intact cells on their intracellular content of 
GTP and CAMP and on an integrated final 
biological effect. The adipocyte fulfills these re- 
quirements, indeed it is possible to follow the 
glycerol and free fatty acid release which is a time- 
dependent process resulting from the cyclic AMP 
controlled lipolysis. 
Here, we show that the obtained results for each 
toxin were self-coherent, i.e., that the GTP and 
cyclic AMP content(s) and the intensity of lipolysis 
were closely correlated in all the experimental con- 
ditions. Nevertheless, these results are difficult to 
interpret according to the current concepts on the 
mode of action of toxins. Indeed, pertussis toxin 
was more efficient than cholera toxin. 
2. MATERIALS AND METHODS 
DL-Isoproterenol HCl (IPNE) (lot I-5627) and 
bovine serum albumin fraction V (made fatty acid 
free as in [17] were from Sigma. Collagenase (163 
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U/mg) was purchased from Worthington Bio- 
chemicals. Cholera toxin (CT) (23.2 LB/pg) pro- 
tein) was a gift from Professor Dodin (Institut 
Pasteur, Paris) and supernatant from cultures of 
B. pertussis strain 8144 (SPT) (2 U LPF/O.l ml) 
from Dr Alonso (Institut Pasteur, Paris). (One 
unit of LPF (lymphocytose-promoting factor) is 
defined as the amount of material that causes lo5 
lymphocytes/ml above background, 3 days after 
injection, i.v. in mouse.) Adenylate cyclase activity 
from SPT was destroyed by heating at 56°C for 30 
min. Residual activity was 2.68% of the initial ac- 
tivity. Although other activities may be present in 
SPT, they do not interfere with the studied 
parameters as the results are identical with those 
obtained with pure islet activating protein (IAP). 
IAP purified approx. 1800 fold from Dr Garcia- 
Sainz was kindly donated by Dr Lafontan. White 
fat cells were isolated by collagenase digestion as in 
[18] from 180 g male Wistar rats. 
Drug and toxins (CT, SPT or IAP) were made 
up freshly in Krebs-Ringer bicarbonate buffer 0.1 
M (pH 7.4) with half the recommended Ca2+ (1.3 
mM) and 4% (w/v) fatty acid-free albumin, except 
for IAP which was dissolved in 0.1 M phosphate 
buffer (pH 7.4) plus 2 M urea as indicated by [19] 
and used at a concentration of lOpg/ml. Identical 
vehicle has no effect on lipolysis or on cyclic-AMP 
production. Free fatty acids were extracted as in 
[20] and determined as in [21]. Triglycerides were 
extracted as in [22]. Aliquots of total lipid extracts 
were saponified in 4% (w/v) in 95% (v/v) ethanol 
for 30 min at 60°C. Glycerol was assayed as in 
[23]. Cyclic AMP was measured by the radioim- 
munological method as in [24], except that bound 
ligand was separated from the free ligand by 
polyethylene glycol precipitation. GTP was 
assayed by the method described in [25] modified 
by J.L. Aublin (unpublished). Nucleotides triphos- 
phate were subjected to controlled barytic hydroly- 
sis yielding the corresponding 3 ‘,5 ‘-cyclic nucleo- 
tide monophosphate in a proportional amount. To 
test the accuracy of the method, ATP level was 
determined in rat fat cells stimulated or not by 
isoproterenol (10e6 M) for 30 min, after substrac- 
tion of control or stimulated cyclic-AMP levels, 
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Fig. 1. Concentration-dependent effects of cholera toxin (a) and crude pertussis toxin (b) on GTP accumulation in rat 
fat cells for 2 h. Data are expressed as the mean + SE of 6 assays. * p < 0.05, ** P = NS. Basal values: (a) 115.7 + 6.2, 
(b) 130.1 f 3.7 pmol/mmol triglyceride. 
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respectively. Obtained values for control (520 
pmolf lo5 cells) and for stimulated adipocytes (340 
pmol/lO’ cells) are similar to those described in 
[261; because of the very low endogenous cyclic- 
GMP content in rat fat cells, stimulated or not, no 
correction for GTP level determination was ef- 
fected. GTP levels were assayed in function of 
weight of adipose tissue during a 2-h incubation 
with or without SPT (1.4 U LPF). The following 
results were obtained: control tissue (no incuba- 
tion) 224 4 27 and 470 + 46 pmol/g and 2 g of 
tissue, respectively (6 assays); 2-h incubation 
without SPT: 251-+- 29 and 487 +_ 29 pmol/g and 2 
g respectively (6 assays); 2-h incubation with SPT: 
562 + 36 and IO42 f 41 pmol/g and 2 g of tissue, 
8 and 5 assays, respectively. 
3. RESULTS 
A concentration-response curve was established 
with CT and SPT, directly added into rat fat cells 
-2 
;5 
@ 
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incubation medium. The treatment induced a CTP 
accumulation in both situations. CT treatment 
(fig.la) for 2 h produced a small increase of GTP, 
leveiling off at 168% for 3 pg/ml; higher concen- 
tration (5 pglml) caused a relative but significant 
decrease of the effect (110010). In the same condi- 
tions, SPT treatment had a very different effect, 
showing a biphasic curve (fig.lb). The first phase, 
up to 1 U LPFlml, presented a concentration- 
dependent increase (EC50 = 0.4 U LPF/mI, max- 
imal effect 24OVo) followed by a rapid and pro- 
nounced decrease for higher concentrations, from 
1.4 to 2 U LPF/ml (residual effect vs basal 13 1%). 
These results were well correlated with the cyclic- 
AMP content, and the glycerol and free fatty acid 
release (fig.2). While for CT all these parameters 
plateaued, as GTP did, at the same concentration. 
with SPT, the cyclic-AMP content decreased as 
observed for GTP but at a higher concentration. 
Beyond this maximum value lipolysis stopped. 
The time-course of the accumulation of GTP 
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Fig.2. Concentration-dependent effect of cholera toxin (a) and crude pertussis toxin (b) on cyclic AMP accumulation, 
glycerol and free fatty acid release by rat fat cells in 2 h incubatian. Data are expressed as the mean rt SE of 3 (a) 
and 4 assays (b). * p< 0.05 for cholera toxin concentration > 1 @g/ml, ** p < 0.01 for pertussis toxin 
concentration > 0.4 U L,FP/mi. 
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Fig.3. Time course of GTP fluctuations in cells stimulated by cholera toxin (5 pg/ml, O--O) (a) or by crude (1.4 U 
LFP/ml, t%-O) or purified pertussis toxin (lOpg/ml, l - - - l ) (b). Results are given as the mean +- SE of 4 (SPT), 
6 (IAP) and 4 (CT). * p < 0.05, ** P = NS. 
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Fig.4. Stimulation by cholera toxin (5 mg/ml) of cyclic AMP accumulation and glycerol and free fatty acid release by 
rat adipocytes. Data are expressed as the mean + SE of 3 assays. * p < 0.05 vs control for incubation time > 60 mm. 
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Fig.5. Stimulation by crude pertussis toxin (1.4 U LPF/ml) of cyclic AMP accumulation and glycerol and free fatty 
acid release by rat adipocytes. Data are expressed as the mean + SE of 4 assays. * p < 0.05 vs control for incubation 
time > 60 min. 
was studied with maximal effective concentrations 
of CT (5 pg/ml) for 3 h (fig.3). The kinetic study 
of CT action (fig.3a) showed a time-dependent 
GTP accumulation with a maximum (230%) ob- 
tained at 90 min, followed by a significant decrease 
to reach a steady-state (160% vs basal) between 2 
and 3 h. This effect of CT on GTP accumulation 
was accompanied by a sustained increase of the 
cyclic-AMP accumulation and a constant rate of 
lipolysis up to 3 h. It was not the case for basal 
lipolysis, though a steady-state of cyclic-AMP ac- 
cumulation was observed (fig.4). 
The kinetic study of the effect of SPT (1.4 U 
LPF/ml) and of IAP (10 fig/ml) on GTP ac- 
cumulation showed identical biphasic curves 
(fig.3b). After a lag time of 30 min, the GTP con- 
tent increased linearly till 90 min (maximal effect 
250 and 400%, respectively), then decreased to 
finally return to the basal value after 3 h. Cyclic 
AMP and lipolysis followed this time-dependent 
increase with a delay. Nevertheless, after a 2-h in- 
cubation, cyclic AMP decreased significantly as 
GTP did, while glycerol and to a lesser extent free 
fatty acid leveled off (fig.5). The results obtained 
with SPT were identical to those obtained with 
pure IAP (not shown). 
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4. DISCUSSION 
The role of GTP in coupling adenylate cyclase 
was firmly established [27,28], nevertheless, its ac- 
tual concentration inside the cell is not known. If 
GTP is equally distributed in the water content of 
adipocyte, we can estimate it in the micromolar 
range. This concentration, which lies in the range 
of, those active on membrane preparations, is very 
low as compared to that in other cell types 
(millimolar in cultured thyroid cells; unpublished 
results) but is high enough to inhibit adenylate 
cyclase [29,30] as well as membrane-bound, low 
K, cyclic-AMP phosphodiesterase [3l] activities of 
rat adipocytes. As described for ATP [32], all the 
cellular GTP content may not participate to the ac- 
tivation of the adenylate cyclase, GTP being se- 
questered in and provided from different pools 
within the cell. 
Our experimental conditions were chosen to 
determine the maximal efficient concentration of 
either toxin and the optimal time of pretreatment, 
on the CAMP accumulation and the lipolytic rate. 
It is interesting to compare the fluctuations of the 
content of GTP with those of CAMP. The maximal 
rise of GTP given by IAP does not exceed 3 fold; 
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it is modest as compared to the range of 4 orders 
of magnitude (10-9-10-5 M) efficient on mem- 
brane preparations [30]. This limited increase pro- 
duces a 7-fold elevation of the CAMP content and 
a lipolysis rate 1.5 times higher. Our results show a 
clear temporal relationship between the cellular 
content of GTP and of CAMP. When the levels of 
both nucleotides return to basal values, the 
stimulation of lipolysis stops. 
The incubation of the cells in the presence of 
cholera toxin produces a small but sustained in- 
crease of the lipolytic rate, very inferior to that ob- 
tained by the stimulation of ,& receptors [33]. This 
difference cannot be explained by the negative ef- 
fect of endogenous adenosine which must be the 
same in both situations. 
Our present results raise more problems than 
they give answers. The very low concentration of 
GTP makes it very sensible to the action of toxins, 
mainly pertussis toxin. It was never reported that 
either cholera toxin or pertussis toxin stimulated 
the production of GTP. Then their positive effect 
on GTP level must be due to an inhibition of their 
disposal. 
The recognized important inhibitory action of 
endogenous adenosine [34] may be prevented by 
the treatment with pertussis toxin. The formation 
of active Ni-GTP is impaired because of the 
decreased rate of GTP-GDP exchange [35,36], 
thus, GTP is protected from hydrolysis by the 
GTPase activity associated to Ni. All available 
GTP can associate to N,, promoting its activation, 
a cyclic-AMP raise and, in turn, the stimulation of 
lipolysis. The hydrolysis of GTP by the GTPase 
activity associated to N, insures a return to basal 
values which occurs after 180 min. At that time the 
cyclic-AMP level has returned to basal and 
lipolysis stopped. Another puzzling observation is 
the loss of efficiency observed with concentrations 
of pertussis toxin higher than 1 U LPF/ml (130 vs 
240% at the maximal efficient dose). A possible 
explanation for this paradoxical result is the shift 
to the left of the time-course curve, when the dose 
of toxin is higher. The maximum effect being 
reached earlier, at 120 min, the decreasing phase is 
already operating. 
The cholera toxin effects, less important, are 
also less transient: the stimulated steady-state 
reached for GTP at 120 min is sustained for 1 h, 
allowing a linear accumulation of cyclic-AMP and 
of lipolysis products. The limited maximal effect 
of cholera toxin, far below that of isoproterenol 
and additive to it [33], may be explained by an in- 
complete ADP-ribosylation of N, subunits. The re- 
maining native N, subunits would be susceptible to 
dissociation under isoproterenol stimulation. This 
hypothesis would explain the observed additivity 
[33] between both stimulators. These data ob- 
tained with intact cells are difficult to integrate 
with the results of acellular experiments. Extensive 
work, evaluating the state of ADP ribosylation of 
the a subunits of the guanine nucleotide regulatory 
components of adenylate cyclase, during the 
stimulation of the cells by the toxins is necessary to 
understand the causes of our observations. 
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